A further market update on the success of leaching tests was released by Noram Ventures (TSXV: NRM) this morning. Subsequent to the prior update, the company has seen the second round of leaching experiments yield up to 1230 ppm lithium, equating to 95% recovery.
The chloride based leaching tests are being conducted by that of Activation Laboratories out of Ancaster, Ontario. The latest results come through the use of a moderate HCI and halide concentration within the solution, as well as moderate temperatures for up to two hours. While the tests yielded 1230 ppm lithium, the original sample had 1290 ppm lithium – equating to 95% recovery.
The latest round of testing has reportedly produced much better results than that of the sulfate-based experiments conducted by the company in 2018. This is notable, given that there is a lower chance for scaling or undesirable mineral precipitation during treatment when using a chloride based solution rather than a sulfate based solution. It also negates the need for a sulfuric acid plant to be built on site, reducing a significant CAPEX item.
The company intends to further optimize the leaching process through further experiments within Q1 2021. The studies are intended to be used for the preliminary economic assessment slated to be completed this year.
Noram Ventures last traded at $0.93 on the TSX Venture.
FULL DISCLOSURE: Noram Ventures is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Noram Ventures on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.